Immunic Inc. (IMUX) Tops Q2 EPS by 1c
Tweet
Share
E-mailGet Alerts IMUX Hot Sheet
Join SI Premium – FREE
Immunic Inc. (NASDAQ: IMUX) reported Q2 EPS of ($0.72), $0.01 better than the analyst estimate of ($0.73).
For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan cuts estimates for Circle and Coinbase on Hyperliquid pressure
- JPMorgan (JPM) Tops Q2 EPS by $2.15, Beats on Revenue
- Goldman Sachs (GS) Tops Q2 EPS by $6.60, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
